Search - tctmd.com

Displaying 641 - 660 of 796

Sort: Relevancy | Date

News Industry News

New Pradaxa® (dabigatran etexilate mesylate) Data to be Presented at American College of Cardiology Scientific Session (ACC.14)

March 24, 2014

News Daily News

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

L.A. McKeown

March 20, 2014

News Daily News

DEFER-STEMI Published: Delayed Stenting Improves Outcomes in Higher-Risk STEMI Patients

March 05, 2014

News Daily News

After PCI, Major Bleeding Predicts Higher Mortality Mainly in Anemic Patients

February 26, 2014

News Daily News

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

January 09, 2014

News Daily News

Comparados con los SMD, los SLE Reducen la Revascularización con Independencia de la Severidad de la Enfermedad Renal

January 09, 2014

News Daily News

Meta-analyses: Novel Anticoagulants Halve Intracranial Hemorrhage vs. Warfarin

January 01, 2014

News Daily News

Bivalirudin Lowers Post-PCI Bleeding Risk Across All Renal Dysfunction Categories

December 10, 2013

Presentation TCT 2013

Outcomes of Patients Treated with Triple Antithrombotic Therapy After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (From the Harmonizing...

Presenter: Eugenia Nikolsky

October 31, 2013

Presentation

Antithrombotic Targets for Treating ACS Patients

Presenter: Philippe Gabriel Steg

October 31, 2013

Presentation

Acute vs. Chronic Antithrombotic Management in ACS: Need for a Paradigm Shift?

Presenter: Gregg Stone

October 31, 2013

Presentation TCT 2013

Advances in Antithrombotic Therapy

Presenter: Anthony DeMaria

October 30, 2013

Presentation TCT 2013

Guideline Strategies for Antithrombotic Therapy in ACS: Contrasting the European and US Perspectives

Presenter: Philippe Gabriel Steg

October 30, 2013

News Conference News TCT 2013

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

October 30, 2013

News Conference News TCT 2013

Intraprocedural ST Predicts Adverse Short-Term Events

October 29, 2013

News Conference News TCT 2013

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

October 29, 2013

News Conference News TCT 2013

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

October 28, 2013

News Industry News

Anti-Clotting Agent Helps Reduce the Risk of Intraprocedural Events during Percutaneous Coronary Intervention

October 28, 2013

News Daily News

SCAI Paper Outlines ‘Best Practices’ for Radial Access

Caitlin E. Cox

October 25, 2013

News Daily News

Hypothermia Does Not Increase Stent Thrombosis Risk in Primary PCI Patients

October 16, 2013

Advertisement

New Pradaxa® (dabigatran etexilate mesylate) Data to be Presented at American College of Cardiology Scientific Session (ACC.14)

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

DEFER-STEMI Published: Delayed Stenting Improves Outcomes in Higher-Risk STEMI Patients

After PCI, Major Bleeding Predicts Higher Mortality Mainly in Anemic Patients

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

Comparados con los SMD, los SLE Reducen la Revascularización con Independencia de la Severidad de la Enfermedad Renal

Meta-analyses: Novel Anticoagulants Halve Intracranial Hemorrhage vs. Warfarin

Bivalirudin Lowers Post-PCI Bleeding Risk Across All Renal Dysfunction Categories

Outcomes of Patients Treated with Triple Antithrombotic Therapy After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (From the Harmonizing...

Antithrombotic Targets for Treating ACS Patients

Acute vs. Chronic Antithrombotic Management in ACS: Need for a Paradigm Shift?

Advances in Antithrombotic Therapy

Guideline Strategies for Antithrombotic Therapy in ACS: Contrasting the European and US Perspectives

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

Intraprocedural ST Predicts Adverse Short-Term Events

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

Anti-Clotting Agent Helps Reduce the Risk of Intraprocedural Events during Percutaneous Coronary Intervention

SCAI Paper Outlines ‘Best Practices’ for Radial Access

Hypothermia Does Not Increase Stent Thrombosis Risk in Primary PCI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content